These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37605794)

  • 1. 'I went for rehab many times and it never worked, but the harm reduction process has given me renewed hope'. Perceptions on the effectiveness of harm reduction and community-based opioid substitution therapy.
    Nyashanu T; Scheibe A; Visser M
    Health Promot J Austr; 2023 Aug; ():. PubMed ID: 37605794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.
    Goeieman DS; Nonyane DS; Nzaumvila DK; Anse van Rensburg MNS
    Afr J Prim Health Care Fam Med; 2023 Jan; 15(1):e1-e10. PubMed ID: 36744456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm reduction in practice - The Community Oriented Substance Use Programme in Tshwane.
    Scheibe A; Shelly S; Hugo J; Mohale M; Lalla S; Renkin W; Gloeck N; Khambule S; Kroukamp L; Bhoora U; Marcus TS
    Afr J Prim Health Care Fam Med; 2020 May; 12(1):e1-e6. PubMed ID: 32501031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.
    Goeieman DS; Nonyane DS; Nzaumvila DK; Janse van Rensburg MNS
    Afr J Prim Health Care Fam Med; 2023 Nov; 15(1):4033. PubMed ID: 38044893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing pharmacy services in opioid substitution treatment.
    Chaar BB; Wang H; Day CA; Hanrahan JR; Winstock AR; Fois R
    Drug Alcohol Rev; 2013 Jul; 32(4):426-34. PubMed ID: 23442133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting 6-month retention among people with opioid use disorders accessing outpatient methadone maintenance therapy in Tshwane, South Africa.
    Gloeck NR; Harris BN; Webb EM; Scheibe A
    S Afr Med J; 2020 Dec; 111(1):68-73. PubMed ID: 33404009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions and experiences of patients attending an opioid substitution clinic in South Africa.
    Domingo AK; Pasche S; Jarvis L; Weich L
    S Afr J Psychiatr; 2022; 28():1936. PubMed ID: 36569808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on privacy in the pharmacy: The views of opioid substitution treatment clients.
    Le PP; Braunack-Mayer A
    Res Social Adm Pharm; 2019 Aug; 15(8):1021-1026. PubMed ID: 30777646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to management of opioid withdrawal in hospitals in England: a document analysis of hospital policies on the management of substance dependence.
    Harris M; Holland A; Lewer D; Brown M; Eastwood N; Sutton G; Sansom B; Cruickshank G; Bradbury M; Guest I; Scott J
    BMC Med; 2022 Apr; 20(1):151. PubMed ID: 35418095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
    Saulle R; Vecchi S; Gowing L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senior nurses' perspectives on the transfer of opioid substitution treatment clients from clinics to community pharmacy.
    Bui J; Day C; Hanrahan J; Winstock A; Chaar B
    Drug Alcohol Rev; 2015 Sep; 34(5):495-498. PubMed ID: 25302986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
    Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
    Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid Substitution Treatment Planning in a Disaster Context: Perspectives from Emergency Management and Health Professionals in Aotearoa/New Zealand.
    Blake D; Lyons A
    Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27834915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness.
    Deering DEA; Sheridan J; Sellman JD; Adamson SJ; Pooley S; Robertson R; Henderson C
    Addict Behav; 2011 Jun; 36(6):636-642. PubMed ID: 21276664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directly observed hepatitis C treatment with opioid substitution therapy in community pharmacies: A qualitative study.
    Gunn J; Higgs P
    Res Social Adm Pharm; 2020 Sep; 16(9):1298-1301. PubMed ID: 31003763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provision of opioid substitution therapy services in Australian pharmacies.
    Chaar BB; Hanrahan JR; Day C
    Australas Med J; 2011; 4(4):210-6. PubMed ID: 23393513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conspicuous by their abstinence: The limited engagement of heroin users in English and Welsh Drug Recovery Wings.
    Page G; Templeton L; Grace S; Roberts P; McKeganey N; Russell C; Liebling A; Kougiali Z; Lloyd C
    Int J Drug Policy; 2016 Mar; 29():49-56. PubMed ID: 26809934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "They accept me, because I was one of them": formative qualitative research supporting the feasibility of peer-led outreach for people who use drugs in Dakar, Senegal.
    Stengel CM; Mane F; Guise A; Pouye M; Sigrist M; Rhodes T
    Harm Reduct J; 2018 Feb; 15(1):9. PubMed ID: 29486774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
    Treloar C; Rance J;
    Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.